Equities

Brooks Laboratories Ltd

BROOKS:NSI

Brooks Laboratories Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)147.47
  • Today's Change-3.01 / -2.00%
  • Shares traded25.94k
  • 1 Year change+48.36%
  • Beta2.1454
Data delayed at least 15 minutes, as of Sep 20 2024 10:44 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income(196)(354)(239)
Depreciation/depletion187074
Non-Cash items2102737
Cash taxes paid, supplemental(1.99)1.533.04
Cash interest paid, supplemental7.962231
Changes in working capital(129)112(246)
Total cash from operations(97)(145)(374)
INVESTING
Capital expenditures(4.39)(4.68)(232)
Other investing and cash flow items, total6.219.62(17)
Total cash from investing1.824.95(249)
FINANCING
Financing cash flow items(7.96)154713
Total cash dividends paid------
Issuance (retirement) of stock, net113----
Issuance (retirement) of debt, net(8.7)(40)(73)
Total cash from financing96114641
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash1.02(26)17
Net cash-begin balance/reserved for future use0.23268.84
Net cash-end balance/reserved for future use1.260.2326
SUPPLEMENTAL INCOME
Depreciation, supplemental187074
Cash interest paid, supplemental7.962231
Cash taxes paid, supplemental(1.99)1.533.04
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.